Enhanced target gene knockdown by a bifunctional shRNA: a novel approach of RNA interference.
about
Stathmin is dispensable for tumor onset in micePhase I trial of "bi-shRNAi(furin)/GMCSF DNA/autologous tumor cell" vaccine (FANG) in advanced cancerPDX1 associated therapy in translational medicineRNA Interference and Cancer TherapyPDX-1 is a therapeutic target for pancreatic cancer, insulinoma and islet neoplasia using a novel RNA interference platformLiver-Specific Inactivation of the Proprotein Convertase FURIN Leads to Increased Hepatocellular Carcinoma Growth.Current progress of siRNA/shRNA therapeutics in clinical trials.Proprotein convertase inhibition: Paralyzing the cell's master switches.Phase 1 Trial of Bi-shRNA STMN1 BIV in Refractory Cancer.Design of Effective Primary MicroRNA Mimics With Different Basal Stem Conformations.Preclinical Justification of pbi-shRNA EWS/FLI1 Lipoplex (LPX) Treatment for Ewing's Sarcoma.Personalized cancer approach: using RNA interference technology.Vertically integrated translational studies of PDX1 as a therapeutic target for pancreatic cancer via a novel bifunctional RNAi platform.Pancreatic cancer actionable genes in precision medicine and personalized surgery.Assessment of intravenous pbi-shRNA PDX1 nanoparticle (OFHIRNA-PDX1) in yucatan swine.Preclinical Biodistribution and Safety Evaluation of a pbi-shRNA STMN1 Lipoplex after Subcutaneous Delivery.Cancer targeting vaccines: surrogate measures of activity.Ewing's Sarcoma: Development of RNA Interference-Based Therapy for Advanced Disease.A combination of paclitaxel and siRNA-mediated silencing of Stathmin inhibits growth and promotes apoptosis of nasopharyngeal carcinoma cells.KRAS mutant allele-specific expression knockdown in pancreatic cancer model with systemically delivered bi-shRNA KRAS lipoplex.
P2860
Q21134036-2C5A61AC-3363-4C7A-A715-4D570C129023Q24625197-B3A899E3-C04E-4B19-B812-7F9349833E14Q26744079-58CB773C-020E-40C2-8F77-E18A034726DCQ29392204-A24D75DE-A5A1-46AE-A5DF-714637CA3993Q34384217-D1F99123-D5D6-40A9-865D-31E22F6E9358Q35763764-D7FDAF88-9B7C-413D-8F9A-91A7F42D54F3Q36071638-A0135BA8-5CCE-4EC0-912B-44B0E82C3A79Q36358957-6695E621-7995-41D7-85D3-6A8CAEFECA0FQ36756699-32B17948-5828-4171-AE9A-E87DC66CE499Q37234566-8C3F7A0E-A111-46F2-B758-EFCF0A00A110Q37256170-06DC76BF-EB1A-418F-A0F6-6A397981B802Q37873825-9B724BA0-51E9-4786-9949-91CFA2C1AF0EQ38181359-252ECB95-9978-4944-9D49-DB42D2C71EF6Q38884916-2716E6C1-CEDC-4270-A902-4185C9685F8DQ39052429-FF1283B8-09D0-4930-AF2F-7BC746395AE3Q39213655-C61952B6-3D48-4D83-8B57-1F415942E2BBQ41222516-5C51BA9A-51A8-4E43-9406-3D6D33F56B4CQ42006104-D0107BA7-47AE-47AA-BE7C-8D0FEF067C81Q51768727-B7844B89-3A57-48AF-909C-50216A984792Q55263196-2E887945-504E-4120-B0BF-55EF1EA9D81F
P2860
Enhanced target gene knockdown by a bifunctional shRNA: a novel approach of RNA interference.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Enhanced target gene knockdown ...... approach of RNA interference.
@en
Enhanced target gene knockdown ...... approach of RNA interference.
@nl
type
label
Enhanced target gene knockdown ...... approach of RNA interference.
@en
Enhanced target gene knockdown ...... approach of RNA interference.
@nl
prefLabel
Enhanced target gene knockdown ...... approach of RNA interference.
@en
Enhanced target gene knockdown ...... approach of RNA interference.
@nl
P2093
P2860
P356
P1433
P1476
Enhanced target gene knockdown ...... approach of RNA interference.
@en
P2093
A P Phadke
B O Pappen
D Dylewski
D Shanahan
P2860
P2888
P304
P356
10.1038/CGT.2010.35
P577
2010-07-02T00:00:00Z